Home Tools
Log in
Cart

Search Result

Search Results for " ly2228820 dimesylate "

2

Compounds

Cat No. Product Name Synonyms Targets
T6047 Ralimetinib dimesylate LY2228820 dimesylate,Ralimetinib,LY2228820,Ralimetinib Mesylate Apoptosis , p38 MAPK , Autophagy
Ralimetinib dimesylate (LY2228820 dimesylate) is the dimesylate salt form of LY2228820, a tri-substituted imidazole derivative and orally available, p38 mitogen-activated protein kinase (MAPK) inhibitor with potential an...
T16721 Ralimetinib LY2228820 Others
Ralimetinib selectively inhibits phosphorylation of MK2 (Thr334) and has no effect on phosphorylation of p38α MAPK, JNK, ERK1/2, c-Jun, ATF2, or c-Myc. Ralimetinib is an effective and selective, ATP-competitive inhibitor...
TargetMol